Orange Book product · Generic (ANDA)
DIHYDROERGOTAMINE MESYLATE
DIHYDROERGOTAMINE MESYLATE
At a glance
Aug 18, 2023
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 18, 2023
2 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
DIHYDROERGOTAMINE MESYLATE
Strength
1MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 215623
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DIHYDROERGOTAMINE MESYLATE
- 2025BREKIYA (AUTOINJECTOR)Brand (NDA)
NDA 215400 · AMNEAL
- 2025ATZUMIBrand (NDA)
NDA 217901 · SATSUMA PHARMS
- 2021TRUDHESABrand (NDA)
NDA 213436 · IMPEL PHARMS
- 1997MIGRANALBrand (NDA)
NDA 020148 · BAUSCH
- —D.H.E. 45Brand (NDA)
NDA 005929 · BAUSCH
- 2025DIHYDROERGOTAMINE MESYLATEGeneric (ANDA)
ANDA 215228 · SOMERSET THERAPS LLC
- 2025DIHYDROERGOTAMINE MESYLATEGeneric (ANDA)
ANDA 216747 · BAXTER HLTHCARE CORP
- 2024DIHYDROERGOTAMINE MESYLATEGeneric (ANDA)
ANDA 212334 · CIPLA
- 2023DIHYDROERGOTAMINE MESYLATEGeneric (ANDA)
ANDA 216881 · RUBICON RESEARCH
- 2022DIHYDROERGOTAMINE MESYLATEGeneric (ANDA)
ANDA 214105 · AMNEAL
- 2020DIHYDROERGOTAMINE MESYLATEGeneric (ANDA)
ANDA 212907 · CIPLA
- 2020DIHYDROERGOTAMINE MESYLATEGeneric (ANDA)
ANDA 211393 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
